On Thursday, Shares of Advanced Micro Devices, Inc. (NASDAQ:AMD), subtract -1.96% and closed at $6.49 in the last trading session. The last trading range of the stock ranges between $6.24 and $6.54. The CCIX consortium recently declared that it has tripled its membership and has released the specification to consortium members. Founding members, AMD, ARM, Huawei, IBM, Mellanox Technologies, Qualcomm Technologies Inc., and Xilinx, Inc., welcome new members representing silicon providers and ecosystem partners in design, verification, software, and systems:
Avery Design Systems
Cadence Design Systems, Inc.
Integrated Device Technology, Inc.
Keysight Technologies, Inc.
Micron Technology, Inc.
Red Hat Inc.
CCIX allows processors based on different instruction set architectures to extend their cache coherency to accelerators, interconnect, and I/O. These highly capable accelerators become a key component in the processor system. The availability of the CCIX technology gives system designers the flexibility to choose the right combination of heterogeneous components from multiple vendors and address their specific system needs.
Range Resources Corp. (NYSE:RRC), jumped 3.60% and closed at $39.11 in the last trading session. The last trading range of the stock ranges between $37.81 and $39.92. The company’s Market capitalization is $6.58 Billion with the total Outstanding Shares of 170.09 million. RANGE RESOURCES CORPORATION (RRC) declared recently that its third quarter 2016 financial results news release will be issued Tuesday, October 25 after the close of trading on the New York Stock Exchange.
A conference call to review the financial results is planned on Wednesday, October 26 at 9:00 a.m. ET (8:00 a.m. CT). To take part in the call, please dial 866-900-7525 and provide conference code 92858145 about 10 minutes before the planned start time.
GlaxoSmithKline plc (ADR) (NYSE:GSK), jumped 0.74% and closed at $42.39 in the last trading session. The last trading range of the stock ranges between $41.60 and $42.58. During the 52-week trading session the minimum price at which share price traded, registered at $37.81 and reached to max level of $45.58. GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, counting vaccines, over-the-counter medicines, and health-related consumer products worldwide. The company offers pharmaceutical products in the therapeutic areas, counting respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, and emesis, dermatology, rare diseases, immuno-inflammation, vaccines, and HIV. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health areas. The companys wellness products include Panadol and Panadol Cold & Flu for headache, joint pain, fever, and cold symptoms; ENO and Tums that are immediate relief antacids; and Nicorette (US), Nicoderm, NiQuitin CQ, and Nicabate for the treatment of nicotine withdrawal as an aid to smoking reduction and cessation. Its oral health products comprise Sensodyne to treat and prevent dental sensitivity and acid erosion; Polident, Poligrip, and Corega to enhance comfort of fitted dentures and to clean dentures; and Aquafresh for the prevention of caries, gum disease, and bad breath. The companys nutrition products include Horlicks, a nutritional beverages and food; and skin health products comprise Physiogel, a face and body care product for dry, sensitive, and irritated skin, in addition to Zovirax and Abreva to treat and prevent the onset of cold sores.